Loading...

GH Research PLC

GHRSNASDAQ
Healthcare
Biotechnology
$14.49
$0.25(1.76%)

GH Research PLC (GHRS) Stock Overview

Explore GH Research PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.9/100

Key Financials

Market Cap898.8M
P/E Ratio-20.53
EPS (TTM)$-0.79
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 Week$13.06
1 Month$12.09
3 Months$12.49
1 Year Target$9.25

GHRS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GH Research PLC (GHRS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.04, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -20.53 and a market capitalization of 898.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;